U.S. pharmaceutical company Viatris has been fined 7.58 million dirhams ($760,000) by Morocco’s competition authority for failing to notify the regulator of its merger, according to two anonymous sources cited by Reuters. The fine stems from the company’s 2020 formation through the merger of Mylan, which operates a subsidiary in Morocco, and Pfizer’s Upjohn division.
Featured News
Democrats Question Big Tech Ballroom Donations Amid Antitrust Concerns
Dec 4, 2025 by
CPI
US Solicitor General Urges Supreme Court to Turn Away Duke Energy Antitrust Case
Dec 4, 2025 by
CPI
Russia Blocks Snapchat and FaceTime in Expanding Crackdown
Dec 4, 2025 by
CPI
Front Row Motorsports Owner Details Major Financial Losses in NASCAR Antitrust Trial
Dec 4, 2025 by
CPI
OpenAI Ordered to Turn Over Millions of ChatGPT Records in Ongoing Copyright Battle
Dec 4, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Intellectual Property
Nov 19, 2025 by
CPI
Dealing in Intellectual Property: IP Justifications and Defenses in Digital Markets Cases
Nov 19, 2025 by
Jennifer Dixton
The Evolving Role of Innovation Theories of Harm in the Antitrust Analysis of Life Science Mergers
Nov 19, 2025 by
Michelle Yost Hale, Matthew D. McDonald & Merrill Stovroff
Who Can Fix It? Antitrust, IP Rights, and the Right to Repair
Nov 19, 2025 by
Rosa M. Morales
Copyright, Antitrust, and the Politics of Generative AI
Nov 19, 2025 by
Daryl Lim